456 related articles for article (PubMed ID: 2690940)
1. Cross-linking of a monomeric 39/34-kDa dispase fragment of von Willebrand factor (Leu-480/Val-481-Gly-718) to the N-terminal region of the alpha-chain of membrane glycoprotein Ib on intact platelets with bis(sulfosuccinimidyl) suberate.
Andrews RK; Gorman JJ; Booth WJ; Corino GL; Castaldi PA; Berndt MC
Biochemistry; 1989 Oct; 28(21):8326-36. PubMed ID: 2690940
[TBL] [Abstract][Full Text] [Related]
2. Purification of botrocetin from Bothrops jararaca venom. Analysis of the botrocetin-mediated interaction between von Willebrand factor and the human platelet membrane glycoprotein Ib-IX complex.
Andrews RK; Booth WJ; Gorman JJ; Castaldi PA; Berndt MC
Biochemistry; 1989 Oct; 28(21):8317-26. PubMed ID: 2557900
[TBL] [Abstract][Full Text] [Related]
3. Identification of aspartic acid 514 through glutamic acid 542 as a glycoprotein Ib-IX complex receptor recognition sequence in von Willebrand factor. Mechanism of modulation of von Willebrand factor by ristocetin and botrocetin.
Berndt MC; Ward CM; Booth WJ; Castaldi PA; Mazurov AV; Andrews RK
Biochemistry; 1992 Nov; 31(45):11144-51. PubMed ID: 1359905
[TBL] [Abstract][Full Text] [Related]
4. Binding of a novel 50-kilodalton alboaggregin from Trimeresurus albolabris and related viper venom proteins to the platelet membrane glycoprotein Ib-IX-V complex. Effect on platelet aggregation and glycoprotein Ib-mediated platelet activation.
Andrews RK; Kroll MH; Ward CM; Rose JW; Scarborough RM; Smith AI; López JA; Berndt MC
Biochemistry; 1996 Sep; 35(38):12629-39. PubMed ID: 8823201
[TBL] [Abstract][Full Text] [Related]
5. Identification of a site in the alpha chain of platelet glycoprotein Ib that participates in von Willebrand factor binding.
Vicente V; Houghten RA; Ruggeri ZM
J Biol Chem; 1990 Jan; 265(1):274-80. PubMed ID: 2104618
[TBL] [Abstract][Full Text] [Related]
6. Mocarhagin, a novel cobra venom metalloproteinase, cleaves the platelet von Willebrand factor receptor glycoprotein Ibalpha. Identification of the sulfated tyrosine/anionic sequence Tyr-276-Glu-282 of glycoprotein Ibalpha as a binding site for von Willebrand factor and alpha-thrombin.
Ward CM; Andrews RK; Smith AI; Berndt MC
Biochemistry; 1996 Apr; 35(15):4929-38. PubMed ID: 8664285
[TBL] [Abstract][Full Text] [Related]
7. Expression and characterization of functionally active fragments of the platelet glycoprotein (GP) Ib-IX complex in mammalian cells. Incorporation of GP Ib alpha into the cell surface membrane.
Meyer S; Kresbach G; Häring P; Schumpp-Vonach B; Clemetson KJ; Hadváry P; Steiner B
J Biol Chem; 1993 Sep; 268(27):20555-62. PubMed ID: 8376410
[TBL] [Abstract][Full Text] [Related]
8. Identification of discontinuous von Willebrand factor sequences involved in complex formation with botrocetin. A model for the regulation of von Willebrand factor binding to platelet glycoprotein Ib.
Sugimoto M; Mohri H; McClintock RA; Ruggeri ZM
J Biol Chem; 1991 Sep; 266(27):18172-8. PubMed ID: 1917949
[TBL] [Abstract][Full Text] [Related]
9. Structure and function of the von Willebrand factor A1 domain: analysis with monoclonal antibodies reveals distinct binding sites involved in recognition of the platelet membrane glycoprotein Ib-IX-V complex and ristocetin-dependent activation.
De Luca M; Facey DA; Favaloro EJ; Hertzberg MS; Whisstock JC; McNally T; Andrews RK; Berndt MC
Blood; 2000 Jan; 95(1):164-72. PubMed ID: 10607699
[TBL] [Abstract][Full Text] [Related]
10. Functional modulation of the isolated glycoprotein Ib binding domain of von Willebrand factor expressed in Escherichia coli.
Sugimoto M; Ricca G; Hrinda ME; Schreiber AB; Searfoss GH; Bottini E; Ruggeri ZM
Biochemistry; 1991 May; 30(21):5202-9. PubMed ID: 2036386
[TBL] [Abstract][Full Text] [Related]
11. Isolation of the von Willebrand factor domain interacting with platelet glycoprotein Ib, heparin, and collagen and characterization of its three distinct functional sites.
Mohri H; Yoshioka A; Zimmerman TS; Ruggeri ZM
J Biol Chem; 1989 Oct; 264(29):17361-7. PubMed ID: 2477370
[TBL] [Abstract][Full Text] [Related]
12. Expression of the phenotypic abnormality of platelet-type von Willebrand disease in a recombinant glycoprotein Ib alpha fragment.
Murata M; Russell SR; Ruggeri ZM; Ware J
J Clin Invest; 1993 May; 91(5):2133-7. PubMed ID: 8486780
[TBL] [Abstract][Full Text] [Related]
13. Isolation and functional characterization of the von Willebrand factor-binding domain located between residues His1-Arg293 of the alpha-chain of glycoprotein Ib.
Vicente V; Kostel PJ; Ruggeri ZM
J Biol Chem; 1988 Dec; 263(34):18473-9. PubMed ID: 3263968
[TBL] [Abstract][Full Text] [Related]
14. Site-directed mutagenesis of a soluble recombinant fragment of platelet glycoprotein Ib alpha demonstrating negatively charged residues involved in von Willebrand factor binding.
Murata M; Ware J; Ruggeri ZM
J Biol Chem; 1991 Aug; 266(23):15474-80. PubMed ID: 1651333
[TBL] [Abstract][Full Text] [Related]
15. Purification and preliminary characterization of the glycoprotein Ib complex in the human platelet membrane.
Berndt MC; Gregory C; Kabral A; Zola H; Fournier D; Castaldi PA
Eur J Biochem; 1985 Sep; 151(3):637-49. PubMed ID: 3161731
[TBL] [Abstract][Full Text] [Related]
16. Studies on anti-von Willebrand factor (vWF) monoclonal antibody NMC-4, which inhibits both ristocetin- and botrocetin-induced vWF binding to platelet glycoprotein Ib.
Fujimura Y; Usami Y; Titani K; Niinomi K; Nishio K; Takase T; Yoshioka A; Fukui H
Blood; 1991 Jan; 77(1):113-20. PubMed ID: 1984791
[TBL] [Abstract][Full Text] [Related]
17. Identification of amino acid residues essential for von Willebrand factor binding to platelet glycoprotein Ib. Charged-to-alanine scanning mutagenesis of the A1 domain of human von Willebrand factor.
Matsushita T; Sadler JE
J Biol Chem; 1995 Jun; 270(22):13406-14. PubMed ID: 7539426
[TBL] [Abstract][Full Text] [Related]
18. Binding of the von Willebrand factor A1 domain to histone.
Ward CM; Tetaz TJ; Andrews RK; Berndt MC
Thromb Res; 1997 Jun; 86(6):469-77. PubMed ID: 9219327
[TBL] [Abstract][Full Text] [Related]
19. The von willebrand factor domain-mediating botrocetin-induced binding to glycoprotein IB lies between Val449 and Lys728.
Fujimura Y; Holland LZ; Ruggeri ZM; Zimmerman TS
Blood; 1987 Oct; 70(4):985-8. PubMed ID: 3498523
[TBL] [Abstract][Full Text] [Related]
20. Conformational changes in the A3 domain of von Willebrand factor modulate the interaction of the A1 domain with platelet glycoprotein Ib.
Obert B; Houllier A; Meyer D; Girma JP
Blood; 1999 Mar; 93(6):1959-68. PubMed ID: 10068669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]